The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-4-(2-methyl-1H-indol-3-yl)-6-(3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)-8-propyl-4H-chromene-3-carbonitrile ID: ALA5284498
Max Phase: Preclinical
Molecular Formula: C31H27N5O2
Molecular Weight: 501.59
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1cc(-c2nc3ccccc3c(=O)n2C)cc2c1OC(N)=C(C#N)C2c1c(C)[nH]c2ccccc12
Standard InChI: InChI=1S/C31H27N5O2/c1-4-9-18-14-19(30-35-25-13-8-6-11-21(25)31(37)36(30)3)15-22-27(23(16-32)29(33)38-28(18)22)26-17(2)34-24-12-7-5-10-20(24)26/h5-8,10-15,27,34H,4,9,33H2,1-3H3
Standard InChI Key: WDJIRJCLGOUBCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
3.2272 -1.1480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5113 -0.7381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7900 -1.1538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0757 -0.7415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0736 0.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7895 0.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5093 0.0928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2240 0.5048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9387 0.9168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7849 1.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1109 1.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3647 2.6060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1955 2.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4553 1.8202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2636 1.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8154 2.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5560 3.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7447 3.2313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3271 1.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3565 0.4989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3585 0.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3576 -0.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 -1.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3595 -1.9865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0729 0.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7926 0.0832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5056 0.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5056 1.3309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7905 1.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0729 1.3290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7905 2.5675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2227 1.7415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9387 1.3309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9387 0.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2227 0.0822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3591 -2.4015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3543 1.7439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3591 -3.2313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 2 0
5 6 1 0
2 7 2 0
7 6 1 0
7 8 1 0
9 8 3 0
10 6 1 0
11 10 2 0
12 11 1 0
13 12 1 0
14 13 2 0
14 10 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
13 18 1 0
19 11 1 0
5 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
4 23 1 0
24 23 1 0
25 21 1 0
26 25 2 0
27 26 1 0
28 27 2 0
28 29 1 0
25 30 1 0
30 29 1 0
31 29 2 0
28 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
27 35 1 0
24 36 1 0
30 37 1 0
36 38 1 0
M END Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.59Molecular Weight (Monoisotopic): 501.2165AlogP: 5.56#Rotatable Bonds: 4Polar Surface Area: 109.72Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.35CX LogP: 5.61CX LogD: 5.61Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -0.68
References 1. Sardar A, Ansari A, Gupta S, Sinha S, Pandey S, Rai D, Kumar M, Bhatta RS, Trivedi R, Sashidhara KV.. (2022) Design, synthesis and biological evaluation of new quinazolinone-benzopyran-indole hybrid compounds promoting osteogenesis through BMP2 upregulation., 244 [PMID:36219902 ] [10.1016/j.ejmech.2022.114813 ]